#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Acute myeloid leukaemia Neoplasm malignant Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Hepatocellular carcinoma Dementia Alzheimer's type Asthma Dermatitis atopic Breast cancer metastatic Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Hepatoblastoma Loss of consciousness Optic glioma Cholestatic pruritus Nephroblastoma Plasma cell myeloma recurrent Acute graft versus host disease in liver Haematological malignancy Cushing's syndrome Marginal zone lymphoma refractory Peritoneal neoplasm Oesophageal adenocarcinoma stage III Osteosarcoma metastatic Primary mediastinal large B-cell lymphoma Amyotrophic lateral sclerosis More trials…

    Learn about Rare Diseases

    Glomerulonephritis membranous – Treatment Mast cell activation syndrome – Trials in Disease Chronic granulomatous disease – Treatment Behcet’s syndrome – Diagnostics Hairy cell leukaemia recurrent – Life with Disease Synovial sarcoma – Life with Disease Congenital hypotransferrinaemia – Life with Disease Gaucher’s disease type III – Basic Information Combined immunodeficiency – Life with Disease Von Willebrand’s disease – Treatment More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Db-Oto-5 Chlorhexidine Gluconate Litifilimab Hydroxocobalamin Belumosudil Mesilate Gallium (68Ga) GSKVX000000030918 Lapatinib Cx-044933 Teplizumab Pegenzileukin Ifinatamab Deruxtecan Gilteritinib Tilmanocept Abrocitinib Tominersen SOVATELTIDE Antiemetics And Antinauseants Sildenafil Citrate Pravastatin Sodium More therapies…

    Learn about Your Condition

    Notalgia paraesthetica Crohn's disease Polycystic liver disease Post-acute COVID-19 syndrome Cardiac failure acute Metachromatic leukodystrophy Monkeypox Small cell lung cancer Exudative retinopathy Soft tissue sarcoma Eye disorder Multifocal motor neuropathy Transplant rejection Facial paresis Primary amyloidosis More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Diabetic neuropathy

  • A study testing capsaicin patches compared to placebo for patients with painful diabetic nerve damage to assess effects on nerve symptoms and nerve fibers

    Recruiting

    2 1 1
    Investigated Diseases:
    • Diabetic neuropathy
    Investigated Drugs:
    • Capsaicin
    Germany

  • Study on the Effectiveness and Safety of VX-993 and Pregabalin for Pain Relief in Patients with Diabetic Peripheral Neuropathy

    Recruiting

    2 1 1
    Investigated Diseases:
    • Diabetic neuropathy
    Investigated Drugs:
    • VX-993
    • Pregabalin
    France Germany Italy

  • Study of Incobotulinumtoxin-A Injections for Diabetic Neuropathic Pain in the Lower Limbs

    Recruiting

    2 1 1
    Investigated Diseases:
    • Diabetic neuropathy
    Investigated Drugs:
    • Clostridium Botulinum Neurotoxin Type A (150Kd), Free Of Complexing Proteins
    Denmark

  • Study of the effectiveness and safety of alpha-lipoic acid and benfotiamine for the treatment of symptoms in patients with diabetic neuropathy

    Not yet recruiting

    2 1 1 1
    Investigated Diseases:
    • Diabetic neuropathy
    Investigated Drugs:
    • Benfotiamine
    Hungary

  • A study testing TRV045 for pain relief in healthy adults to understand its effects on nerve pain from diabetic peripheral neuropathy

    Not recruiting

    1 1
    Investigated Diseases:
    • Diabetic neuropathy
    Investigated Drugs:
    • TRV045
    The Netherlands

  • Study on Medical Cannabis Aerosol for Treating Diabetic Nerve Pain in Patients Using Syqe Inhaler

    Not recruiting

    2 1
    Investigated Drugs:
    • Cannabis Sativa Flower
    Czechia Germany Poland
1 2
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!